Search clinical trials for: Investigational Drug, MW-III

Total 9009 results

DUSA Pharmaceuticals, Inc.

Completed

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Actinic Keratosis

United States
DUSA Pharmaceuticals, Inc.

Withdrawn

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Actinic Keratosis

United States
Skingenix, Inc.

Recruiting

Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

Burns

United States
Seqirus

Completed

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Influenza

Australia, New Zealand, Philippines, South Africa
Yağmur Saraç Gül
Recep Tayyip Erdogan University Scientific Research Projects Coordinator

Completed

Efficacy of Green and White Tea Extract Mouthwashes in the Management of Plaque-induced Gingivitis: A Clinical and Biochemical Study

Inflammation | Oxidative Stress | Gingivitis; Chronic

Turkey
Universidade Estadual Paulista Júlio de Mesquita...

Completed

Low Power Laser in Mandibular Third Molar Surgery

Laser Therapy, Low-Level
University Hospital, Gasthuisberg

Completed

Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer (LiverMWA1)

Liver Neoplasms

Belgium
American-European Congress of Ophthalmic Surgery

Terminated

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Keratoconus | Corneal Ectasia

United States, Puerto Rico
Postgraduate Institute of Medical Education and...

Completed

Efficacy of Mw Vaccine in Treatment of Severe Sepsis (MISS)

Septic Shock | Severe Sepsis | Immune Modulation

India
Fudan University

Completed

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial (TACE+RFA)

Hepatocellular Carcinoma

China
Merck Sharp & Dohme LLC

Terminated

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

Alzheimer Disease

United States
GlaxoSmithKline

Completed

An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.

Epilepsy

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients

Visual Acuity

United States
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center; NYU Langone Health

Completed

Study of ADI-PEG 20 in Patients With Advanced Melanoma

Skin Cancer | Metastatic Melanoma | Neoplasm

United States
GlaxoSmithKline

Completed

Single Dose Escalation First Time in Human PK Study

Infections, Bacterial

Australia
Umbria Bioengineering Technologies

Recruiting

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

Breast Cancer

Spain, Italy
Umbria Bioengineering Technologies

Completed

Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection (DE-17-17)

Breast Cancer

Italy, Spain
Pfizer

Completed

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Pfizer

Completed

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

Multiple Myeloma

United States
Avelas Biosciences, Inc.
Clinipace Worldwide; RRD International, Inc.

Completed

Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Stage I Breast Cancer | Stage II Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer Female | Stage III Breast Cancer | Carcinoma Breast | Primary Invasive Malignant Neoplasm of Female Breast

United States
Cancer Intelligence Care Systems, Inc.
Stella Pharma Corporation

Completed

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Angiosarcoma | Malignant Melanoma

Japan
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Tetanus Immunisation (Healthy Volunteers) | Diphtheria Immunisation (Healthy Volunteers) | Pertussis Immunisation (Healthy Volunteers)

Canada
GlaxoSmithKline

Active, not recruiting

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Sexually Transmitted Diseases

United States, Germany, Philippines, France, Spain, South Africa, United Kingdom, Brazil
Introgen Therapeutics
M.D. Anderson Cancer Center

Unknown

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Neoplasm Metastasis | Malignant Melanoma

United States
Seqirus

Completed

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

Influenza, Human

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Influenza

United States
Sudhalkar Eye Hospital

Completed

TLR-9 Antagonism in Steroid Resistant Optic Neuritis

Optic Neuritis

India
Boston Scientific Corporation

Completed

The EVOLVE China Clinical Trial (EVOLVE-CHINA)

Coronary Artery Disease

China
VIST - Faculty of Applied Sciences
Slovenian Research Agency; Tosla d.o.o.

Completed

The Effect of 12-week Dietary Intake of Food Supplements Containing Collagen on Dermis Density and Other Skin Parameters (TO-COSKIN)

Wrinkles | Skin Elasticity | Skin Hydration | Trans Epidermal Water Loss (TEWL) | Dermis Density | Dermis Thickness | Skin Texture

Slovenia
Novartis

Completed

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

Epilepsy | Seizures

Germany
Oslo University Hospital

Unknown

Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL). (CXL)

Keratoconus | Corneal Ectasia
GlaxoSmithKline

Completed

Prevention of Seasonal Affective Disorder

Seasonal Affective Disorder (SAD)

United States, Canada
Umbria Bioengineering Technologies

Recruiting

Clinical Investigation to Evaluate the Suitability of StrokeWave in Distinguishing Haemorragic From Ischaemic Strokes

Stroke, Ischemic | Stroke Hemorrhagic

Italy
Amgen

Completed

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Systemic Lupus Erythematosus

United States
University Children's Hospital Basel
Permamed AG, Switzerland; Galvita AG, Switzerland

Completed

Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions (CHILD-IVITAB)

Bioequivalence

Switzerland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age

Influenza

United States, Canada
Mead Johnson Nutrition

Completed

Acceptance Of A Partially-Hydrolyzed Infant Formula

Stool

United States
GlaxoSmithKline

Completed

Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.

Metastatic Breast Cancer | Neoplasms, Breast

United States
Duke University
National Institute on Drug Abuse (NIDA)

Recruiting

Low Nicotine Cigarettes, Smoking, and Chronic Pain (VLNCPain)

Chronic Pain | Smoking, Cigarette

United States
International AIDS Vaccine Initiative
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines

HIV Infections

Kenya, Zambia, Uganda
Mead Johnson Nutrition
Baylor College of Medicine

Completed

Assessing Early Behavioral Indicators of Formula Tolerance

Tolerance

United States
Princess Maxima Center for Pediatric Oncology
European Commission

Recruiting

CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients

Acute Myeloid Leukemia in Children

Netherlands
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Respiratory Syncytial Virus Infections

Canada, Australia, United States, Germany, Japan, South Africa
GlaxoSmithKline

Active, not recruiting

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above (RSV OA=ADJ-023)

Respiratory Syncytial Virus Infections

Spain, Japan, Italy, United States, Australia, Canada, Korea, Republic of, Germany
GlaxoSmithKline

Active, not recruiting

Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

Respiratory Syncytial Virus Infections

United States, Finland, Germany, Japan, Taiwan
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children

Influenza

Germany
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Belgium
NovaDigm Therapeutics, Inc.
United States Department of Defense; Cetero Research, San Antonio

Completed

Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida

Candidiasis | Staphylococcal Infections

United States
Meissa Vaccines, Inc.

Completed

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Respiratory Syncytial Virus Infections

United States

3

Subscribe